HEATHER CALHOUN: Open Payments
NPI 1649303041 · BROOKVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,261 in 75 payments from 18 companies in 2025. Trend: 2023 $934 · 2024 $1,475 · 2025 $1,261
Food & beverage: $1,261
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $191 |
| ABBVIE INC. | 13 | $177 |
| PFIZER INC. | 12 | $160 |
| Lilly USA, LLC | 7 | $142 |
| Amgen Inc. | 6 | $107 |
| Phathom Pharmaceuticals, Inc. | 5 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $84 |
| GlaxoSmithKline, LLC. | 4 | $68 |
| Exact Sciences Corporation | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
Products named: MOUNJARO, JARDIANCE, UBRELVY, VOQUEZNA, ELIQUIS, TRELEGY ELLIPTA, QULIPTA, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
